Nurix Therapeutics (NASDAQ:NRIX) reported quarterly losses of $(0.87) per share which missed the analyst consensus estimate of $(0.79) by 10.13 percent. This is a 2.35 percent decrease over losses of $(0.85) per share from the same period last year.
Here’s How Much You Would Have Made Owning Axsome Therapeutics Stock In The Last 5 Years
Axsome Therapeutics (NASDAQ:AXSM) has outperformed the market over the past 5 years by 52.74% on an annualized basis producing an average annual return of 64.23%. Currently, Axsome Therapeutics has a market capitalization of $2.35 billion.
